In this article, we will delve into the topic of Naflocort, which has generated great interest and discussion in different areas. In order to fully understand its importance and impact, we will explore its origins, evolution and impact on today's society. Through a detailed analysis, we will examine the various perspectives and opinions that exist around Naflocort, as well as the possible implications it has in the current context. Likewise, we will delve into relevant case studies that will help to better understand its scope and relevance today. By collecting updated and relevant information, we aim to generate a debate around Naflocort that will enrich knowledge and promote deep reflection on this significant topic.
Clinical data | |
---|---|
Other names | SQ-26490; 9α-Fluoro-1',4'-dihydro-11β,21-dihydroxy-2'betaH-naphtho(2',3':16α,17α)pregna-1,4-diene-3,20-dione |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C29H33FO4 |
Molar mass | 464.577 g·mol−1 |
3D model (JSmol) | |
| |
|
Naflocort (developmental code name SQ-26490) is a synthetic glucocorticoid corticosteroid which was never marketed.